Global Endocrine Peptide Test market size is expected to reach $14.88 billion by 2030 at 8.1%, segmented as by dehydroepiandrosterone sulphate (dhea-s), immunoassay tests, enzyme-linked immunosorbent assay (elisa), radioimmunoassay (ria)
Read More
Global Encephalomyelitis market size is expected to reach $30.84 billion by 2030 at 6.4%, impact of growing autoimmune diseases on market growth
Read More
Global Encephalitis Treatment market size is expected to reach $29.68 billion by 2030 at 6.2%, segmented as by primary encephalitis, viral encephalitis, bacterial encephalitis, fungal encephalitis, parasitic encephalitis
Read More
Global Emphysema market size is expected to reach $6.19 Billion by 2030 at 4.6%, rise in respiratory infections driving the growth of the market due to increasing disease progression
Read More
The Disease Registry Software market will reach $2.64 billion by 2030 at 11.1%, driven by personalized medicine and patient-centric digital registries.
Read More
The global Disease Forecasting Platform market will reach $7.96 billion by 2030 at 23.6%, driven by AI-powered predictive analytics, real-time surveillance
Read More
The global Direct-to-Patient Digitaling market will reach $8.84 billion by 2030 at 17.3%, driven by patient-centric care and real-time digital health solutions.
Read More
Global Direct-To-Consumer (DTC) Laboratory Testing market size is expected to reach $18.4 billion by 2025.1 at 25.1%, segmented as by blood, blood glucose, cholesterol
Read More
The Direct-To-Consumer (DTC) Genetic Testing market size is projected to reach $4.45 billion in 2030 at a CAGR of 15.7%, driven by AI-based genetic interpretation
Read More
Global Direct To Consumer Testing market size is expected to reach $4.51 billion by 2030 at 14.8%, e-commerce growth fuels market expansion
Read More